These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11152917)

  • 1. Effects of estrone sulfate alone or with medroxyprogesterone acetate on serum lipoprotein levels in postmenopausal women.
    Luciano AA; Miller BE; Schoenenfeld MJ; Schaser RJ;
    Obstet Gynecol; 2001 Jan; 97(1):101-8. PubMed ID: 11152917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
    Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy.
    Adachi JD; Sargeant EJ; Sagle MA; Lamont D; Fawcett PD; Bensen WG; McQueen M; Nazir DJ; Goldsmith CH
    Br J Obstet Gynaecol; 1997 Jan; 104(1):64-70. PubMed ID: 8988699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    Climacteric; 1999 Sep; 2(3):181-8. PubMed ID: 11910595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels.
    Notelovitz M; Katz-Karp S; Jennings D; Lancaster J; Green EM; Stoll RW
    Obstet Gynecol; 1990 Jul; 76(1):65-70. PubMed ID: 2193271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
    Nand SL; Wren BG; Gross BA; Heller GZ
    Obstet Gynecol; 1999 Jun; 93(6):1009-13. PubMed ID: 10362172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
    Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
    Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
    Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic effects of delta-8-estrone sulfate in postmenopausal women.
    Bhavnani BR; Cecutti A; Dey MS
    J Soc Gynecol Investig; 1998; 5(3):156-60. PubMed ID: 9614646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Taechakraichana N; Holinka CF; Haines CJ; Subramaniam R; Tian XW; Ausmanas MK
    Climacteric; 2007 Jun; 10(3):225-37. PubMed ID: 17487649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
    Nand SL; Webster MA; Baber R; O'Connor V
    Obstet Gynecol; 1998 May; 91(5 Pt 1):678-84. PubMed ID: 9572210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
    Wolfe BM; Koval JJ; Nisker JA
    Am J Obstet Gynecol; 1998 Apr; 178(4):787-92. PubMed ID: 9579445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP; Lee N; Soong YK
    J Reprod Med; 1998 Jul; 43(7):568-74. PubMed ID: 9693406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of oral estrone versus 17 beta-estradiol on lipoproteins in postmenopausal women.
    Colvin PL; Auerbach BJ; Koritnik DR; Hazzard WR; Applebaum-Bowden D
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1568-73. PubMed ID: 2347894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
    Lobo RA; Bush T; Carr BR; Pickar JH
    Fertil Steril; 2001 Jul; 76(1):13-24. PubMed ID: 11438314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.